MEDIKINET MR 20 MG MODIFIED-RELEASE CAPSULES

Country: Израел

Језик: Енглески

Извор: Ministry of Health

Активни састојак:

METHYLPHENIDATE HYDROCHLORIDE 20 MG

Доступно од:

MEDILINE LTD.

АТЦ код:

N06BA04

Фармацеутски облик:

MODIFIED RELEASE CAPSULES

Пут администрације:

PER OS

Произведен од:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

Терапеутска група:

METHYLPHENIDATE

Терапеутске индикације:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

Датум одобрења:

2011-05-01